ArticleBMC pulmonary medicine2026
Association between non-HDL-cholesterol to HDL-cholesterol ratio (NHHR) and COPD: a cross-sectional study of 11,082 Chinese adults with predictive nomogram development.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeChronic obstructive pulmonary disease (COPD) poses a growing public health burden in China, yet reliable biomarkers for risk stratification remain limited. The non–high-density lipoprotein cholesterol (non–HDL-C) to high-density lipoprotein cholesterol (HDL-C) ratio (NHHR) has recently been proposed as an integrated lipid index, but its association with COPD is unclear in Asian populations. PATIENTS AND
methodsWe analyzed data from 11,082 adults aged ≥ 45 years in the 2015 wave of the China Health and Retirement Longitudinal Study (CHARLS). COPD was defined by physician diagnosis. NHHR was calculated as (total cholesterol (TC) – HDL-C)/HDL-C. Logistic regression models, restricted cubic splines, and subgroup analyses were used to evaluate the association between NHHR and COPD. A predictive nomogram was developed and validated using receiver operating characteristic (ROC) and calibration analyses.
resultsOverall, 16.9% (n = 1,601) of participants had COPD. In fully adjusted models, higher NHHR was significantly associated with a lower risk of COPD (highest vs. lowest quartile: OR = 0.75, 95% CI: 0.64–0.89, P < 0.001). The inverse association was linear and consistent across most subgroups, particularly in older adults and those with hypertension, diabetes, or chronic kidney disease (CKD). In multivariable feature selection, NHHR, male sex, older age, lower education, cardiovascular disease (CVD), and CKD were independent predictors of COPD. A nomogram incorporating these predictors demonstrated moderate discrimination (area under the curve, AUC = 0.67) and good calibration.
conclusionsNHHR is inversely associated with COPD prevalence among middle-aged and older Chinese adults and may serve as a simple lipid-based biomarker for risk stratification. These findings highlight the potential role of lipid metabolism in COPD pathogenesis. The NHHR-based predictive model appears to hold potential clinical value for the prevention of COPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.